HTH

HTH is a global life science investment firm headquartered in Milan, Italy. The firm specializes in biotech, medtech, and digital health sectors, with a particular emphasis on AI-enabled technologies. HTH typically participates in Series A investment rounds, providing significant capital to early-stage companies aiming to scale their innovations in the healthcare industry.

Notable portfolio companies include Airgo, which has raised $1 million, and Leuko, which has raised $5 million. HTH's investment philosophy centers on supporting groundbreaking technologies that can transform healthcare. The firm offers strategic guidance and industry expertise to its portfolio companies, leveraging its deep network and experience in the life sciences sector to drive growth and innovation.